ART Advanced Research Technologies Inc. is a leader in molecular imaging products for the healthcare and pharmaceutical industries. ART has developed products in medical imaging, medical diagnostics, disease research, and drug discovery with the goal of bringing new and better treatments to patients faster. The Optix® optical molecular imaging system, designed for monitoring physiological changes in living systems at the preclinical study phases of new drugs, is used by industry and academic leaders worldwide. The SoftScan® optical medical imaging device is designed to improve the diagnosis and treatment of breast cancer. Finally, the Fenestra® line of molecular imaging contrast products provide image enhancement for a wide range of preclinical Micro CT applications allowing scientists to see greater detail in their imaging studies, with potential extension into other major imaging modalities. ART is commercializing some of these products in a global strategic alliance with GE Healthcare. TSX ticker symbol: ARA.
Areas of Expertise:
For information or updates contact Sources at
or see our current publications and services online:
The Sources Directory
Include
yourself in Sources Media Names & Numbers
Sources
Calendar News
Releases Parliamentary
Names & Numbers
© Sources 1977-2012. The information provided
is copyright and may not be reproduced in any form or by any means (whether
electronic, mechanical or photographic), or stored in an electronic
retrieval system, without written permission of the publisher. The content
may not be resold, republished, or redistributed. Indexing and search applications by Ulli Diemer and Chris DeFreitas.